Smart dosing model aims to protect young transplant patients
NCT ID NCT06095895
First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 15 times
Summary
This study tested a computer program that helps doctors give the right dose of anti-rejection drugs to children who have had a kidney transplant. The program uses drug levels from blood tests to predict future exposure and adjust doses. 29 children participated, and the goal was to see how accurate the predictions were.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Radboudumc
Nijmegen, Gelderland, 6500HB, Netherlands
Conditions
Explore the condition pages connected to this study.